🇺🇸 FDA
Patent

US 10357570

Methods of treating nausea utilizing semi-solid delivery vehicle compositions comprising granisetron

granted A61KA61K31/439A61K31/445

Quick answer

US patent 10357570 (Methods of treating nausea utilizing semi-solid delivery vehicle compositions comprising granisetron) held by Heron Therapeutics, Inc. expires Mon Jul 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Heron Therapeutics, Inc.
Grant date
Tue Jul 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/439, A61K31/445, A61K31/573, A61K31/765